Integrated Management of Stroke Risk in Brain Cancer: Insights from the Tumoral Bleeding Classification System and <i>CanStroke</i> Protocol

Brain cancer-associated stroke represents a complex interplay of oncological and cerebrovascular factors, distinct from conventional stroke mechanisms. Tumor-induced hypercoagulability, inflammation, and vascular disruption converge to create a unique clinical challenge that demands precision in diagnosis and management. This review synthesizes current evidence on the pathophysiological mechanisms, diagnostic innovations, and therapeutic strategies for brain cancer-related stroke while introducing two transformative frameworks designed to improve patient outcomes. We propose the Tumoral Bleeding Classification System (TBCS), a novel phenotypic framework categorizing tumoral bleeding into intratumoral and peritumoral subtypes, with further subdivisions to guide clinical decision-making. By linking these classifications to diagnostic biomarkers, such as D-dimer, and advanced imaging techniques, such as magnetic resonance imaging, the TBCS may enhance risk stratification and therapeutic targeting. Building on these insights, the CanStroke protocol offers an integrated, multidisciplinary, evidence-based management strategy tailored for brain cancer patients at risk of stroke. This protocol bridges oncology, neurology, and vascular medicine to address key challenges, including early recognition of stroke risk, individualized treatment plans, and mitigation of complications. Central to this approach is the integration of molecular diagnostics and pharmacogenomic data to optimize treatment pathways, aligning with precision medicine principles. This article highlights the critical need for diagnostic-therapeutic frameworks in brain cancer-related stroke, underscoring the value of the TBCS and CanStroke protocol in transforming care. By linking diagnostic biomarkers, imaging techniques, and therapeutic strategies, these innovations pave the way for improved survival, reduced morbidity, and enhanced quality of life in this vulnerable population.

Authors

Institutions

Publication Details

Journal
Journal of Stroke Medicine
Published
2025-04-26
DOI
https://doi.org/10.1177/25166085251335378
Citations
1
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
1.87
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrated Management of Stroke Risk in Brain Cancer: Insights from the Tumoral Bleeding Classification System and CanStroke Protocol

Helen Shen, Sonu Bhaskar, Spiro Menounos
1 citations
Journal of Stroke Medicine
Venous Thromboembolism Diagnosis and Management
1.87
article

Integrated Management of Stroke Risk in Brain Cancer: Insights from the Tumoral Bleeding Classification System and CanStroke Protocol

Helen Shen, Sonu Bhaskar, Spiro Menounos
article en
1 citations

Abstract

Brain cancer-associated stroke represents a complex interplay of oncological and cerebrovascular factors, distinct from conventional stroke mechanisms. Tumor-induced hypercoagulability, inflammation, and vascular disruption converge to create a unique clinical challenge that demands precision in diagnosis and management. This review synthesizes current evidence on the pathophysiological mechanisms, diagnostic innovations, and therapeutic strategies for brain cancer-related stroke while introducing two transformative frameworks designed to improve patient outcomes. We propose the Tumoral Bleeding Classification System (TBCS), a novel phenotypic framework categorizing tumoral bleeding into intratumoral and peritumoral subtypes, with further subdivisions to guide clinical decision-making. By linking these classifications to diagnostic biomarkers, such as D-dimer, and advanced imaging techniques, such as magnetic resonance imaging, the TBCS may enhance risk stratification and therapeutic targeting. Building on these insights, the CanStroke protocol offers an integrated, multidisciplinary, evidence-based management strategy tailored for brain cancer patients at risk of stroke. This protocol bridges oncology, neurology, and vascular medicine to address key challenges, including early recognition of stroke risk, individualized treatment plans, and mitigation of complications. Central to this approach is the integration of molecular diagnostics and pharmacogenomic data to optimize treatment pathways, aligning with precision medicine principles. This article highlights the critical need for diagnostic-therapeutic frameworks in brain cancer-related stroke, underscoring the value of the TBCS and CanStroke protocol in transforming care. By linking diagnostic biomarkers, imaging techniques, and therapeutic strategies, these innovations pave the way for improved survival, reduced morbidity, and enhanced quality of life in this vulnerable population.

Journal of Stroke MedicineVol. 8(1)
New South Wales Department of Health (AU), Liverpool Hospital (AU), UNSW Sydney (AU), National Cerebral and Cardiovascular Center (JP), Ingham Institute (AU), South Western Sydney Local Health District (AU)
Openalex Percentile: Top 18%
Venous Thromboembolism Diagnosis and Management
1.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.